Skip to main content
. 2019 Sep 3;2019(9):CD011749. doi: 10.1002/14651858.CD011749.pub2

NCT03628391.

Trial name or title Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts: a prospective randomized multi‐center double‐blind placebo‐controlled clinical trial (EuRIDICE)
Methods Multi‐site (6), quadruple‐blind, randomized placebo‐controlled trial taking place in the Netherlands. Target enrolment: 742 participants
Participants Adult (≥ 18 years) participants admitted to 1 of 6 participating ICUs and diagnosed with delirium by the CAM‐ICU or ICDSC ≥ 4
Interventions Participants randomized to receive haloperidol, starting with 2.5 mg IV q8h and titrated to a maximum of 5 mg IV q8h, or placebo
Outcomes Primary
  1. Numbers of delirium‐free and coma‐free days in the ICU


Secondary
  1. Time to delirium resolution

  2. 28‐day and 1‐year mortality

  3. Time to readiness of ICU discharge

  4. Adverse drug reaction (e.g. QTc prolongation, arrhythmias, extrapyramidal symptoms)

  5. Patient and family well‐being (ICU Memory Tool)

  6. Delirium Experience Questionnaire (DEQ)

  7. Caregiver Strain Index at discharge and 3 months after randomization

  8. Incidence of post‐traumatic stress disorder in participants and family 3 months after randomization

  9. Maximum ICU mobility scale

  10. Quality of sleep (Richards‐Campbell Sleep Questionnaire)

  11. 3‐ and 12‐month cognitive function (Montreal Cognitive Assessment)

  12. Rey Auditory Verbal Learning Test

  13. Semantic Fluency Digit Span

  14. Trailmaking Tests A and B

  15. Boston Naming Test

  16. Hospital Anxiety and Depression Scale

  17. 3‐ and 12‐month functional outcomes and quality of life (Short Form‐36)

  18. Workload experienced by ICU nurses while caring for delirious patients (based on Delirium Experience Questionnaire)

Starting date February 2018
Contact information Mathieu van der Jagt (m.vanderjagt@erasmusmc.nl)
Notes Study is currently recruiting
Study sponsor: Erasmus Medical Center Rotterdam
Study funded by: ZonMw
Study registered: at https://www.clinicaltrialsregister.eu/ctr‐search/trial/2017‐003115‐20/NL

APACHE: Acute Physiology and Chronic Healh Evaluation.

CAM‐ICU: Confusion Assessment Method for the ICU.

DRS‐R‐98: Delirium Rating Scale ‐ Revised ‐ 98.

DSM: Diagnostic and Statistical Manual.

EEG: electroencephalography.

EQ‐5D‐5L: EuroQoL Group Quality of Life Based on 5 Dimensions ‐ 5‐Level Scale.

ICDSC: Intensive Care Delirium Screening Checklist.

ICU: intensive care unit.

QTc: measure of time between start of the Q wave and end of the T wave in the heart's electrical cycle corrected for heart rate.

RASS: Richmond Agitation‐Sedation Scale.